Premium
Management and outcomes of patients with epiphora referred to a specialist ophthalmic plastic unit
Author(s) -
Sibley Daniel,
Norris Jonathan H,
Malhotra Raman
Publication year - 2013
Publication title -
clinical and experimental ophthalmology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.3
H-Index - 74
eISSN - 1442-9071
pISSN - 1442-6404
DOI - 10.1111/j.1442-9071.2012.02866.x
Subject(s) - medicine , referral , etiology , nasolacrimal duct obstruction , pediatrics , retrospective cohort study , cohort , audit , surgery , family medicine , management , economics
Background To describe the aetiology and management of the symptom epiphora presenting to a specialist ophthalmic service. Design A retrospective case series and patient postal questionnaire of all new referrals seen in a specialist unit with primary symptoms of epiphora between J anuary 2007 and D ecember 2008. The study was begun in 2010 to allow a 2‐year follow‐up for this cohort. Participants Two hundred thirty‐seven patients were identified, of which 192 met the inclusion criteria. Fifty‐seven were male, 135 were female, with a mean age of 60.7 (range 0–95) years. Methods Patients were identified using a key word search of clinic letters and a search of primary care coding. Main Outcome Measures Duration of symptoms, referral source, aetiology and subjective improvement of symptoms post treatment. Results At consultation, patients had experienced epiphora for a mean of 41.1 (range 0.066–360) months. A diagnosis of partial or complete nasolacrimal duct obstruction (31.8%), dry eye with secondary reflex tearing (29.2%), eyelid malposition (10.4%) and multi‐factorial epiphora (28.7%) was made after follow‐up and treatment. A postal questionnaire follow‐up showed that 25% of patients no longer had any epiphora, with 67% reporting an improvement in their symptoms. Final follow‐up was 30–54 months. Conclusions This study highlights the protean aetiology of the symptom and sign, epiphora. Sparse data exist on the audited success in managing this common symptom and sign. This study helps introduce an example of a benchmark for evaluating the effectiveness of epiphora. The majority of patients were referred, usually by ophthalmologists for lacrimal surgery.